These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22309315)

  • 1. Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
    Luizon MR; de Almeida Belo V
    Biomarkers; 2012 May; 17(3):286-8. PubMed ID: 22309315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
    Chaudhary AK; Pandya S; Mehrotra R; Singh M; Singh M
    Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
    Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
    BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
    Chaudhary AK; Pandya S; Mehrotra R; Bharti AC; Jain S; Singh M
    Biomarkers; 2010 Dec; 15(8):684-92. PubMed ID: 20860530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphisms in the promoter region of MMP-2 and MMP-9 and susceptibility to obstructive sleep apnea.
    Cao C; Wu B; Wu Y; Yu Y; Ma H; Sun S; Zhang Q; Ding Q; Chen L; Deng Z
    Sci Rep; 2015 Mar; 5():8966. PubMed ID: 25753939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
    Lin CM; Zeng YL; Xiao M; Mei XQ; Shen LY; Guo MX; Lin ZY; Liu QF; Yang T
    Cell Physiol Biochem; 2017; 42(4):1458-1468. PubMed ID: 28719899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.
    Liutkevicius V; Lesauskaite V; Liutkeviciene R; Vaiciulis P; Uloza V
    In Vivo; 2020; 34(1):267-274. PubMed ID: 31882488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
    Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
    J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
    Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
    PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
    Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
    Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers.
    Singh K; Agrawal NK; Gupta SK; Singh K
    Int J Low Extrem Wounds; 2013 Sep; 12(3):199-204. PubMed ID: 24043671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study.
    Zade PR; Gosavi SR; Hazarey VK; Ganvir SM
    J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27389714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis.
    Saare M; Lamp M; Kaart T; Karro H; Kadastik Ü; Metspalu A; Peters M; Salumets A
    Fertil Steril; 2010 Sep; 94(4):1560-1563. PubMed ID: 20100617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.